Acta Med. 2010, 53: 139-145

https://doi.org/10.14712/18059694.2016.73

Visual Functions after Laser Photocoagulation in Central Serous Chorioretinopathy

Dagmar Hejcmanová, Markéta Macháčková, Eva Rencová, Georgia Kyprianou, Hana Langrová

Charles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Ophtalmology, Hradec Králové, Czech Republic

Received January 27, 2010
Accepted August 18, 2010

References

1. Baran NV, Gürlü VP, Esquin H. Long-term macular function in eyes with central serous chorioretinopathy. Clin Experiment Ophthalmol 2005; 33(4): 369–372. <https://doi.org/10.1111/j.1442-9071.2005.01027.x>
2. Bartos D, Kondrova J, Stibor V, Bartosova L, Rousova A. Changes in psychovisual function after central serous chorioretinopathy. Cesk Slov Oftalmol 1998; 54(3):166–173.
3. Elsner H, Pörksen E, Klatt C, et al. Selective retina therapy in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2006; 244(12): 1638–1645. <https://doi.org/10.1007/s00417-006-0368-5>
4. Ferris FL, Krasoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94:91–96. <https://doi.org/10.1016/0002-9394(82)90197-0>
5. Folk JC, Thompson HS, Han DP, Brown CK. Visual function abnormalities in central serous retinopathy. Arch Ophthalmol 1984; 102(9):1299–1302. <https://doi.org/10.1001/archopht.1984.01040031049021>
6. Frisén L, Frisén M. How good is normal visual acuity? Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1981p; 215(3):149–157. <https://doi.org/10.1007/BF00413146>
7. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium, Idiopathic central serous chorioretinopathy. Am J Ophthalmol 1967; 63:587–615.
8. Genter CR 2nd, Kandel GL, Bedell HR. The minimum angle of resolution vs angle of regard function as measured with different targets. Ophthalmic Physiol Opt. 1981; 1: 3–13. <https://doi.org/10.1016/0275-5408(81)90056-9>
9. Hood DC, Bach M, Brigell M. ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol 2008; 116(1): 1–11. <https://doi.org/10.1007/s10633-007-9089-2> <PubMed>
10. Chappelow AV, Marmor MF. Multifocal electroretinogram abnormalities persist following resolution of central serous chorioretinopathy. Arch Ophthalmol 2000; 118(9):1211–1215. <https://doi.org/10.1001/archopht.118.9.1211>
11. Iida T, Yannuzzi LA, Spaide RF, Borodoker N, Carvalho CA, Negrao S. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 2003; 23(1): 1–7. <https://doi.org/10.1097/00006982-200302000-00001>
12. Khosla PK, Rana DD, Tewari HK, Azad RU, Talvar D. Evaluation of visual function following argon laser photocoagulation in central serous retinopathy. Ophthal Surg Las 1997; 28: 8693–8697.
13. Koskela P, Laatikainen L, von Dickhoff K. Contrast sensitivity after resolution of central serous retinopathy. Graefes Arch Clin Exp Ophthalmol 1994; 232(8): 473–476. <https://doi.org/10.1007/BF00195356>
14. Lai TY, Lai RY, Ngai JW, Chan WM, Li H, Lam DS. First and second-order kernel multifocal electroretinography abnormalities in acute central serous chorioretinopathy. Doc Ophthalmol 2008; 116(1): 29–40. <https://doi.org/10.1007/s10633-007-9075-8>
15. Langrová H, Hejcmanová D, Peregrin J. Reproducibility of contrast sensitivity measurements. Cesk Slov Oftalmol 1996; 52: 52–57.
16. Lanthony P. [Evaluation of the desaturated Panel D-15. I. Method of quantification and normal scores]. J Fr Ophtalmol 1986; 9(12): 843–847.
17. Leaver P, Williams C. Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1979; 63(10): 674–677. <https://doi.org/10.1136/bjo.63.10.674> <PubMed>
18. Lu N, Zhang C. Contrast sensitivity study in fellow eyes of patients with central serous chorioretinopathy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1992; 14(2): 85–88.
19. Maaranen TH, Mäntyjärvi MI. Contrast sensitivity in patients recovered from central serous chorioretinopathy. Int Ophthalmol 1999; 23(1): 31–35. <https://doi.org/10.1023/A:1006496615006>
20. Maaranen TH, Tuppurainen KT, Mäntyjärvi MI. Color vision defects after central serous chorioretinopathy. Retina 2000; 20(6): 633–637. <https://doi.org/10.1097/00006982-200011000-00008>
21. Marmor MF, Tan F. Central serous chorioretinopathy: bilateral multifocal electroretinographic abnormalities. Arch Ophthalmol 1999; 117(2): 184–188. <https://doi.org/10.1001/archopht.117.2.184>
22. Marmor MF, Zrenner E. Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 1998–1999; 97(2): 143–156. <https://doi.org/10.1023/A:1002016531591>
23. Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. International Society for Clinical Electrophysiology of Vision. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009; 118(1): 69–77. <https://doi.org/10.1007/s10633-008-9155-4>
24. Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y. Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 2003; 106(2): 105–115. <https://doi.org/10.1023/A:1022591317907>
25. Miyake Y, Shiroyama N, Ota I, Horiguchi M. Local macular electroretinographic responses in idiopathic central serous chorioretinopathy. Am J Ophthalmol 1988; 106(5): 546–550. <https://doi.org/10.1016/0002-9394(88)90583-1>
26. Moschos M, Brouzas D, Koutsandrea C. Assessment of central serous chorioretinopathy by optical coherence tomography and multifocal electroretinography. Ophthalmologica 2007; 221(5): 292–298. <https://doi.org/10.1159/000104758>
27. Ojima Y, Masanori H, Sasahara M. Three-dimensional imaging of the foveal photoreceptor layer in the sentral serous chorioretinopathy using high-speed optical coherence tomography. Ophthalmology 2007; 114(12): 2197–2207. <https://doi.org/10.1016/j.ophtha.2007.02.015>
28. Ozdemir H, Karacorlu SA, Senturk F, Karacorlu M, Uysal O. Eye. 2008; 22(2): 204–208. <https://doi.org/10.1038/sj.eye.6702563>
29. Piccolino FC, de la Longrais RR, Ravera G, et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol. 2005; 139(1): 87–99. <https://doi.org/10.1016/j.ajo.2004.08.037>
30. Robertson DM, Ilstrup D. Direct, indirect, and laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983; 95: 457–466. <https://doi.org/10.1016/0002-9394(83)90265-9>
31. Sjöstrand J, Frisén L. Contrast sensitivity in macular disease. A preliminary report. Acta Ophthalmol (Copenh) 1977; 55: 507–514. <https://doi.org/10.1111/j.1755-3768.1977.tb06128.x>
32. Sutter EE, Tran D. The field topography of ERG components in man-I. The photopic luminance response. Vision Res 1992; 32(3): 433–446. <https://doi.org/10.1016/0042-6989(92)90235-B>
33. Suzuki K, Hasegawa S, Usui T, et al. Multifocal electroretinogram in patients with central serous chorioretinopathy. Jpn J Ophthalmol 2002; 46(3): 308–314. <https://doi.org/10.1016/S0021-5155(02)00477-X>
34. Taban M, Boyer DS, Thomas EL. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004; 137: 1073–1080. <https://doi.org/10.1016/j.ajo.2004.01.043>
35. Vajaranant TS, Szlyk JP, Fishman GA, Gieser JP, Seiple W. Localized retinal dysfunction in central serous chorioretinopathy as measured using the multifocal electroretinogram. Ophthalmology 2002; 109(7): 1243–1250. <https://doi.org/10.1016/S0161-6420(02)01065-5>
36. Vingrys AJ, King-Smith PE. A quantitative scoring technique for panel tests of color vision. Invest Ophthalmol Vis Sci 1988; 29(1): 50–63.
37. Yap EY, Robertson DM. The long-term outcome of central serous chorioretinopathy. Arch Ophthalmol 1996; 114: 689–692. <https://doi.org/10.1001/archopht.1996.01100130681007>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Archive